Taihe Group, Inc. (TIHE)
Taihe Group, Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $1.00, up 0.00% on the session, giving a market capitalisation of $71.9M. On trailing twelve-month figures it carries a trailing P/E of -1428.57, a net margin of 0.0%. Its beta of 1.23 implies it has historically moved more than the broad market.
Currently, Taihe Group, Inc. is not engaged in substantial operational activities. Historically, the company functioned as a commercial laboratory, providing specialized predictive tests for chemosensitivity and immunotherapy on biopsy samples, alongside a variety of other laboratory services and products within the field of oncology. Established in 1994, the Scottsdale, Arizona-based entity was formerly known as NuOncology Labs, Inc. until it adopted the name Taihe Group, Inc. in April 2022.
Taihe Group, Inc. is most often compared with the following Healthcare names: